Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet
Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet
Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Non-systemic antacid + Antacid and buffering agent + Raft-forming anti-reflux agent
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Hyperacidity, heartburn and acid indigestion
- Symptomatic relief in peptic ulcer and gastritis
- Gastro-oesophageal reflux symptoms, with alginate
- Rapid relief of acidity, heartburn and indigestion
- Buffer protecting acid-labile PPIs in immediate-release forms
Mechanism of Action
Aluminium Hydroxide — Aluminium hydroxide is a weak base that neutralises hydrochloric acid in the stomach, raising gastric pH and reducing pepsin activity, which relieves acid-related pain and discomfort.
Magnesium Trisilicate — Neutralises gastric acid and forms gelatinous silica that coats the stomach lining; with alginic acid it forms a raft that limits reflux.
Sodium Bicarbonate — Sodium bicarbonate neutralises gastric acid, quickly raising stomach pH. In PPI combinations, this transiently neutral environment protects the PPI from acid breakdown so it can be absorbed rapidly.
Alginic Acid — In the stomach, alginic acid reacts with acid and bicarbonate to form a viscous gel raft that floats on gastric contents, physically limiting reflux of acid into the oesophagus.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Constipation
- Nausea
- Low phosphate levels with prolonged use
- Diarrhoea
- Stomach cramps
- Belching and bloating
Contraindications
- Known hypersensitivity to any component of the formulation
- Severe renal impairment (risk of aluminium accumulation)
- Hypophosphataemia
- Severe kidney impairment
- Reduces absorption of tetracyclines, quinolones and iron
- Sodium-restricted diets: heart failure, hypertension or oedema
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the general range pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
See the full urology range – manufacturer, supplier and PCD franchise: BPH, overactive bladder, kidney-stone, UTI support and men’s-health tablets.
PCD Pharma Franchise & Third Party Manufacturing — Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet
- ✓ Made at WHO-GMP certified partner units — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg. It is a fixed-dose combination of non-systemic antacid, antacid and buffering agent and raft-forming anti-reflux agent. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet brings together Aluminium Hydroxide (antacid), Magnesium Trisilicate (non-systemic antacid), Sodium Bicarbonate (antacid and buffering agent) and Alginic Acid (raft-forming anti-reflux agent) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet in India?
Trumac Healthcare is a supplier of Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet used for?
Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet is used for hyperacidity, heartburn and acid indigestion; symptomatic relief in peptic ulcer and gastritis; gastro-oesophageal reflux symptoms, with alginate; rapid relief of acidity, heartburn and indigestion. It should be used as advised by a registered medical practitioner.
Is Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet available for PCD pharma franchise on monopoly basis?
Yes. Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid?
Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid is a fixed-dose combination of non-systemic antacid, antacid and buffering agent and raft-forming anti-reflux agent (therapeutic class: Fixed-Dose Combination — Non-systemic antacid + Antacid and buffering agent + Raft-forming anti-reflux agent).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Aluminium Hydroxide + Magnesium Trisilicate + Sodium Bicarbonate + Alginic Acid Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Aluminium Hydroxide 80 mg + Magnesium Trisilicate 40 mg + Sodium Bicarbonate 200 mg + Alginic Acid 70 mg Tablet?
